12.11.2024

Drug producer Zentiva plans new production investments in Romania and wants to bring new products to manufacture in Bucharest, explained Simona Cocos, general manager of Zentiva Romania and the more

11.14.2024

Drug producer Zentiva (SCD.RO) on Thursday announced the decision of the Financial Supervisory Authority on the approval of the notice that the majority shareholder Zentiva Group will withdraw the more

10.14.2024

Pharmaceutical producer Zentiva (SCD.RO) on Monday announced the Czech Zentiva Group, its majority shareholder, had come to own more than 96% in it as a result of the tender offer conducted between more

09.19.2024

Pharmaceutical producer Zentiva SA (SCD.RO) on Thursday notified the Bucharest Stock Exchange of the decision of the Financial Supervisory Authority (ASF) to approve the tender offer for its shares more

08.30.2024

Pharmaceutical producer Zentiva (SCD.RO), 96% held by Zentiva Prague and thus not much traded on the Bucharest Stock Exchange, doubled its net profit in the first half of 2024 to around RON143 more

07.05.2024

The most important investment project for pharmaceutical group Zentiva Romania in 2024 is to manufacture at its two plants in Bucharest medical drugs included in the parent company's portfolio. more

06.06.2024

Drugmaker Zentiva Bucuresti (BSE:SCD) has appointed Hacho Agop Hatchikian as temporary member in the company's Board of Directors, effective June 6, Zentiva said in a press statement published on the more

05.15.2024

Drugmaker Zentiva (SCD.RO), held by Prague-based Zentiva Group, reported net profit of RON74.2 million for the first quarter of 2024, compared to RON42.7 million in the same period of 2023, and a more

04.01.2024

Drugmaker Zentiva has budgeted net revenues of above RON1.1 billion in 2024, up 20% from 2023 level, which would mark the company’s joining the RON billionaires’ league. more

11.27.2023

Zentiva Romania’s objectives for the next decade envisage expanding production at the two plants it owns in Bucharest and adding new products to its portfolio. more

11.15.2023

Drugmaker Zentiva (SCD) posted RON124 million net profit in the first nine months of 2023, compared with RON33.6 million in the same period last year, while revenue rose to RON684 million from RON538 more

09.01.2023

Zentiva (SCD.RO), one of the largest pharmaceutical companies in Romania, had a turnover of RON450.6 million in the first six months of 2023, up 24% from the same period in 2022. more

05.16.2023

Pharmaceutical company Zentiva SA had a turnover of RON230 million in January-March 2023, up 36% on the year, and a profit of over RON42 million, almost nine times higher than RON5 million reported in more

04.06.2023

Zentiva Group, held by private equity firm Advent International, has put Zsolt Baranyai in charge of the production operations in Romania, replacing Margareta Tanase, who retired after working for more

04.06.2023

Zentiva (SCD.RO), the largest pharmaceutical company listed on the Bucharest Stock Exchange, though with a low free float of merely 4%, is aiming for net sales of RON856 million and RON101.7 million more

03.22.2023

Zentiva (SCD.RO), one of the largest pharmaceuticals producers in Romania, on Wednesday (March 22) announced in a stock market report that the company’s Board of Directors decided the appointment more

03.01.2023

Pharmaceutical company in 2022 generated RON753 million turnover, up 10%, and RON89 million net profit, 15% lower than in 2021. more

11.16.2022

Pharmaceutical company Zentiva (SCD.RO), held by investment fund Advent International, registered a net turnover of RON538 million in the first nine months of 2022, up 7% on the year, as per the more

09.01.2022

Zentiva Romania, a major pharmaceutical manufacturer in Romania, in the first half of this year posted RON362 million turnover, up 10%, and net profit worth RON31.7 million, 8% lower than in the same more

05.18.2022

Zentiva (SCD.RO) the largest pharmaceutical producer with facilities of its own in Romania, ended the first quarter of 2022 with growth of 7% in revenue to RON169.2 million, compared with the same more

05.10.2022

Zentiva Bucuresti, the medicine plant present in the local market for 60 years, has invested a total EUR44 million over the last 12 years in the production facility based in capital city Bucharest, more

04.05.2022

Zentiva Group, the main producer of generic medicines and the third largest pharmaceutical company in Romania, made 162 million packs of medicines in 2021 at its Zentiva and Labormed plants in capital more

09.01.2021

Zentiva Romania (SCD.RO), one of the largest generics manufacturers in Romania, had a turnover of RON330 million in January-June 2021, up 17% on the year, and a net profit of RON34.5 million, down 17% more

05.17.2021

Zentiva Romania (SCD.RO), one of the largest generics manufacturers in Romania, reported a turnover of RON163 million for the first quarter of 2021, up 6.5% on the year, and a net profit of RON23.6 more

04.29.2021

Generics manufacturer Zentiva Group on Thursday reported sales of around RON1.05 billion in Romania in 2020, of which its factory in Bucharest generated RON558 million, 1% lower than in 2020, the more